Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group AT-hook 1 pseudogene 2 (HMGA1P2, also known as HMGIYL2) is a processed pseudogene located on chromosome 4q13.3 and found only in the human genome[3]. Unlike protein-coding genes, pseudogenes like HMGA1P2 typically do not encode functional proteins; however, preliminary data suggest that HMGA1P2 can be transcribed and possibly translated into protein, potentially acting as a competitor to the HMGA1 wild-type protein[3]. HMGA1P2 can also act as a regulatory RNA, affecting the stability and expression of the functional HMGA1 gene by decoying shared miRNAs or competing for RNA-binding factors[3][4]. This regulatory interplay may impact pathways relevant to oncogenesis and metabolic regulation, though HMGA1P2 itself is not established as a direct therapeutic target, receptor, or enzyme[3]. There is currently no evidence for direct drug interactions with HMGA1P2, and its use as a clinical biomarker or therapeutic target is not documented.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group AT-hook 1 pseudogene 2 (HMGA1P2).